ABRA INVEST ha colaborado con HEMOSOLVE (exploitation of "sclerosing microfoam" for the treatment of haemorrhoids) through the design of a plan to develop its own clinics and agreements with other prestigious institutions.
History of microfoam sclerosants
In 1993 the Cabrera family invented the sclerosing microfoam. Since then it has been used to treat varicose veins effectively in more than 25,000 patients. As well as being treated in Cabrera's own 5 clinics, the treatment is used under licence by prestigious institutions such as the Clínica Universitaria de Navarra and Sanitas hospitals. Following the success of the microfoam treatment for varicose veins, the inventors have developed microfoam for haemorrhoids.
1. Large size of affected population:
3. Advantageous competitive position:
The team composed of technical staff and professionals with business experience in the healthcare world is well prepared to develop the established business plan.
Diego Gutiérrez Zarza